A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4375 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01)
Patent
CA 2623882
This invention relates to dry power aerosol formulations for use with a dry powder inhaler, the formulation comprising the PDE 4 inhibitor N-cyclopropyl-1- [3-(1-oxido-3-pyridinylethynyl)phenyl]-1,4-dihydro[1,8] naphthyridin-4-one-3- carboxamide (Formula I), and sieved lactose for inhalation.
Cette invention concerne des formulations aérosols de poudre sèche destinées à être utilisées avec un inhalateur de poudre sèche, la formulation comprenant l'inhibiteur de PDE 4 N-cyclopropyl-1-[3-(1-oxydo-3-pyridinyléthynyl)phényl]-1,4-dihydro[1,8] naphthyridin-4-one-3-carboxamide (Formule I), et un lactose tamisé pour inhalation.
Meisner Dale
Rossi Joanna
Tanfara Helen
Thibert Roch
Merck Frosst Canada Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Aerosol powder formulation comprising sieved lactose does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aerosol powder formulation comprising sieved lactose, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aerosol powder formulation comprising sieved lactose will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1807739